Medical knowledge
A Linker Protein Gene Therapy Approach For LAMA2-CMD
Dr. Yurchenco (NJ, USA) and Dr. Rüegg (Basel, Switzerland) are collaborating with Santhera Pharmaceuticals to develop an emerging gene therapy…
The knowledge base
-
![]()
Medical knowledge
-
![]()
Research updates
GYM Project – A New European Collaboration
The Generate Your Muscle (GYM) project was recently set up with the aim of developing and commercialising affordable stem cell…
-
![]()
Patient questions
The Experts Answer Your Questions
After being diagnosed with LAMA2-CMD at 39 years old, Cindy experienced 3 seizures, the last being generalised. This prompted brain…
-
![]()
Medical knowledge
Dr. Dwi Kemaladewi On A Promising New Therapeutic Strategy For LAMA2-CMD
Dr. Dwi Kemaladewi is playing a a key role in developing a novel therapeutic approach that has opened new treatment…
-
![]()
Medical knowledge
Prothelia: Developing A Protein Replacement Therapy For LAMA2-CMD
Steven Axon is the CEO of Prothelia, a biopharmaceutical company based in Massachusetts, USA, committed to developing a promising new…
-
![]()
Research updates
Prof. Bert Smeets On The Development Of Autologous Muscle Stem Cell Treatment
Professor Bert Smeets is involved in a number of investigations looking into a muscle stem cell treatment strategy to treat…
The driving forces behind Lama2.com
View all partners
